Sfoglia per Autore
Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients
2004 L. Valenti, T. De Feo, A.L. Fracanzani, E. Fatta, M. Salvagnini, S. Aricò, G. Rossi, G. Fiorelli, S. Fargion
Variables significantly associated with non alcoholic steatohepatitis (NASH) and fibrosis in patients with non alcoholic fatty liver disease (NAFLD)
2006 E. Fatta, L. Valenti, A.L. Fracanzani, E.A. Pulixi, A. Orsatti, P. Pedotti, M. Maggioni, S.R. Fargion
Baseline alt and ferritin predict histological findings in NAFLD
2007 A.L. Fracanzani, L. Valenti, C. Bertelli, E. Fatta, E. Pulixi, S. Fargion
Baseline alt and ferritin predict histological findings in NAFLD
2007 A. L Fracanzani, L. Valenti, E. Fatta, C. Bertelli, E. Pulixi, S. Fargion
Normal ALT NAFLD should not preclude liver biopsy
2007 A.L. Fracanzani, L. Valenti, E. Bugianesi, G. Marchesini, M. Andreoletti, A. Colli, C. Bertelli, E. Fatta, S. Fargion
Contrast-enhanced ultrasonography (CEUS) and spiral computed tomography (CT) in the assessement of efficacy of percutaneous ablation treatments of hepatocellular carcinoma in cirrhosis
2008 A. L Fracanzani, A. Maraschi, L. Burdick, C. Bertelli, E. Fatta, N. Bonelli, D. Meregaglia, S. Fargion
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes
2008 A.L. Fracanzani, L.V.C. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, E. Vanni, C. Bertelli, E. Fatta, D. Bignamini, G. Marchesini, S.R. Fargion
Evaluation of patients with NAFLD with or without increased ALT
2008 A.L. Fracanzani, L. Valenti, E. Bugianesi, G. Marchesini, M. Andreoletti, A. Colli, C. Bertelli, E. Fatta, S. Fargion
Progression of carotic atherosclerotic damage is related to ALT values
2008 A.L. Fracanzani, L.V.C. Valenti, L. Burdick, C. Bertelli, E. Fatta, A. Maraschi, E.A. Pulixi, S.R. Fargion
Effectiveness of Entecavir for the treatment of NUC-naïve chronic hepatitis B patients : a large multicenter cohort study in clinical practice
2008 P. Lampertico, M. Viganò, F. Facchetti, M. Puoti, E. Minola, F. Suter, M. Brunetto, B. Coco, S. Fargion, E. Fatta, P. Del Poggio, M. Pozzi, M. Milanese, G. Colloredo, S. Fagiuoli, L. Pasulo, M. Colombo
Normal ALT should not preclude liver biopsy in patients with NAFLD
2008 A.L. Fracanzani, L. Valenti, E. Bugianesi, G. Marchesini, M. Andreoletti, A. Colli, C. Bertelli, E. Fatta, S. Fargion
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma
2008 M. Sampietro, A.L. Fracanzani, L. Valenti, C. Bertelli, E. Fatta, D. Bignamini, D. Tavazzi, S. Fargion
Iron depletion by phlebotomy improves liver transaminases in patients with nonalcoholic fatty liver disease : a propensity score adjusted analysis
2008 L. Valenti, E. Bugianesi, A.L. Fracanzani, E. Vanni, E. Fatta, P. Dongiovanni, S. Fargion, G. Marchesini
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease
2008 L. Valenti, L. Burdick, C. Bertelli, P. Dongiovanni, R. Rametta, E. Fatta, D. Bignamini, S. Fargion, A.L. Fracanzani
Progression of carotic atherosclerotic damage is related to alt values in patients with non alcoholic fatty liver disease
2008 E.A. Pulixi, L. Burdick, L. Valenti, C. Bertelli, E. Fatta, A. Maraschi, M. Sampietro, S. Fargion, A.L. Fracanzani
The risk of severe liver disease in NAFLD with normal amino-transferase levels : a role for insulin and diabetes
2008 A.L. Fracanzani, L. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, E. Vanni, C. Bertelli, E. Fatta, D. Bignamini, G. Marchesini, M. Sampietro, S. Fargion
Increased ferritin predicts vascular damage in patients with nonalcoholic fatty liver disease
2008 L. Valenti, L. Burdick, C. Bertelli, P. Dongiovanni, R. Rametta, E. Fatta, D. Bignamini, S. Fargion, A.L. Fracanzani
Cell-free DNA in HCV-related cirrhosis and small hepatocellular carcinoma
2008 M. Sampietro, A.L. Fracanzani, L. Valenti, C. Bertelli, E. Fatta, D. Bignamini, D. Tavazzi, S. Fargion
Entecavir is an effective treatment for NUC-naive chronic hepatitis B patients in clinical practice : 48-week data from a large multicenter cohort study
2009 P. Lampertico, M. Viganò, F. Facchetti, F. Suter, E. Minola, O. Fracassetti, G. Carosi, M. Puoti, G. Rizzardini, G. Gubertini, C. Magni, P. Del Poggio, S. Fargion, E. Fatta, M. Brunetto, B. Coco, G. Colloredo, M. Pozzi, M. Milanese, S. Fagiuoli, L. Pasulo, M. Borzio, M. Quagliuolo, M. Iavarone, G. Lunghi, M. Colombo
Effectiveness of entecavir for the treatment of NUC-naïve chronic hepatitis B patients : A large multicenter cohort study in clinical practice
2009 P. Lampertico, M. Viganò, F. Facchetti, E. Minola, F. Suter, M. Puoti, M. Brunetto, B. Coco, S.R. Fargion, E. Fatta, P. Del Poggio, M. Pozzi, M. Milanese, G. Colloredo, S. Fagiuoli, L. Pasulo, M.A. Iavarone, M. Colombo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile